Tag

Intercept

All articles tagged with #intercept

NATO Intercepts Russian Long-Range Flight Over Baltic Sea
europe1 month ago

NATO Intercepts Russian Long-Range Flight Over Baltic Sea

NATO jets scrambled to intercept two Tu-22M3 strategic bombers and about 10 escort fighters over the Baltic Sea for more than four hours as part of the Baltic air-policing mission, with French Rafales from Lithuania and jets from Sweden, Finland, Poland, Denmark and Romania monitoring the Russian flight. Moscow said the mission was planned and conducted in neutral waters in compliance with international rules. Interceptions on NATO’s eastern flank are routine, and Lithuania reported four scrambles between April 13–19 to address flight-rule violations such as transponder-off or no flight plan.

military1 month ago

NORAD Intercepts Violating Aircraft Over Palm Beach as TFR Enforced

NORAD F-16s intercepted a general aviation aircraft over Palm Beach, Florida, after it violated a Temporary Flight Restriction on March 29, 2026; the aircraft was escorted out and NORAD dispensed flares for visibility. Pilots should contact 121.5 or 243.0 and turn around until receiving further instructions, and always verify FAA NOTAMs, especially in sensitive regions.

world3 months ago

NORAD tracks Russian aircraft near Alaska in routine ADIZ activity

NORAD detected and tracked two Tu-95s, two Su-35s, and one A-50 operating in the Alaskan ADIZ on Feb. 19, 2026. It dispatched two F-16s, two F-35s, one E-3, and four KC-135s to intercept, positively identify, and escort them until they departed; the aircraft remained in international airspace and did not enter U.S. or Canadian sovereign airspace. NORAD said the activity is routine and not a threat.

FDA Raises Concerns Over Intercept's NASH Treatment, Stock Drops.
pharmaceuticals3 years ago

FDA Raises Concerns Over Intercept's NASH Treatment, Stock Drops.

The FDA has released briefing documents ahead of an advisory committee meeting stating that Intercept's Ocaliva cannot be justified for use in NASH subjects with Stage 2 or 3 fibrosis. This comes after the FDA rejected Intercept's push for accelerated approval in 2020. Meanwhile, X4 Pharmaceuticals has released more positive data from its Phase III study of mavorixafor as a treatment of WHIM syndrome, and PTC Therapeutics has claimed a Phase III win in rare genetic disease phenylketonuria. The FDA will also review Takeda's enzyme replacement therapy for an ultra-rare blood clotting disorder, and Canadian biotech enGene plans to combine with a Forbion-led blank check company to land a seat on Nasdaq and get to an FDA approval request in the first half of 2025.